We focus on development and international commercialization of patented and clinically validated life-science projects, especially digital health and nutraceutical projects, including functional food. New development directions in the sector and in patients’ approach to their health, have led to new trends in products designed to help patients actively take part in monitoring and caring about their own health.

The Adiuvo Group is an experienced, international team with an outstanding knowledge of the life science sector. Years of practical experience, an excellent awareness of the needs of today’s market, and extensive international activity allow us not only to accurately evaluate potential projects, but also choose the best path for their commercialization and market success.

Our projects follow global trends. Our main focus is on new technologies in the sector. We select projects that address the need to enhance preventive measures, strengthen patients’ engagement in the health monitoring process, and promote their active participation in their treatment.

By ensuring the protection of intellectual property, validating technologies in clinical trials, and by acquiring market certification for new products, we are able to commercialize projects based on various business models and do so on an international scale.

We pay special attention to keeping our investors and the business community properly informed. We believe that adequate communication is key to maintaining good mutual relations based on reliable information about the company’s ongoing business. How we do our work has a direct effect on our mutual success.